Volume 13, Issue 2 (May 2025)
Res Mol Med (RMM) 2025, 13(2): 131-140 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghaderi S, Tarahomjoo S. Designing Anticancer Peptides Based on Diphtheria Toxin, CRM197 and HB-EGF-like Growth Factor Interactions. Res Mol Med (RMM) 2025; 13 (2) :131-140
URL: http://rmm.mazums.ac.ir/article-1-613-en.html
URL: http://rmm.mazums.ac.ir/article-1-613-en.html
1- Department of Central Laboratory, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran.
2- Department of Antigen Studies, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. ,starahomjoo@gmail.com
2- Department of Antigen Studies, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran. ,
Keywords: Anti-cancer peptides, Diphtheria toxin (DT), Epidermal growth factor receptor (EGFR), Heparin-binding epidermal growth factor-like growth factor (HB-EGF), Molecular dynamics (MD)simulations
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
